Sponsor-Investigators

Thomas E. Hutson

GU09-145

Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors

Status

Closed

Cancer Types

Kidney

Locations